Ligand validation:3UKF

FDA: DIHYDROFLAVINE-ADENINE DINUCLEOTIDE

FDA is a Ligand Of Interest in 3UKF designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
3UKF_FDA_B_600	100%	10%	0.026	0.995	2.22	2.05	19	19	0	0	100%	1
3UKF_FDA_A_600	100%	10%	0.03	0.994	2.21	2.07	17	19	0	0	100%	1
3UKF_FDA_C_600	100%	10%	0.033	0.994	2.19	2.08	16	19	1	0	100%	1
3UKF_FDA_G_600	100%	10%	0.031	0.992	2.22	2.08	18	19	5	0	100%	1
3UKF_FDA_F_600	100%	10%	0.032	0.992	2.22	2.06	19	18	1	0	100%	1
3UKF_FDA_H_600	100%	11%	0.035	0.992	2.21	2.02	16	19	0	0	100%	1
3UKF_FDA_D_600	100%	10%	0.036	0.993	2.18	2.08	18	18	1	0	100%	1
3UKF_FDA_E_600	100%	11%	0.036	0.993	2.21	2.04	16	20	0	0	100%	1
4U8P_FDA_B_601	93%	12%	0.086	0.98	2.5	1.64	19	10	0	0	100%	1
3UTF_FDA_B_511	86%	11%	0.106	0.975	2.69	1.59	25	9	0	0	100%	1
4U8O_FDA_B_601	85%	10%	0.119	0.984	2.73	1.57	22	9	0	0	100%	1
4WX1_FDA_C_601	85%	10%	0.104	0.968	2.7	1.63	24	10	0	0	100%	1
3UTH_FDA_B_511	85%	10%	0.108	0.972	2.66	1.64	23	10	0	0	100%	1
4OPD_FDA_B_501	100%	67%	0.02	0.995	0.55	0.71	-	1	2	0	100%	1
3TSH_FDA_A_601	100%	38%	0.04	0.992	1.03	1.38	3	6	3	0	100%	1
4MOR_FDA_B_801	100%	15%	0.037	0.989	1.83	1.96	12	19	1	0	100%	1
4OPC_FDA_A_501	100%	64%	0.038	0.986	0.6	0.76	-	2	1	0	100%	1
3ATR_FDA_A_501	100%	23%	0.039	0.986	1.34	1.81	5	16	1	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.